CID 156594291(1499193-54-2)
- Name: CID 156594291
- Synonyms:1499193-54-2;(2R)-2-aminobutan-1-ol;(6S)-5-[(2-methylpropan-2-yl)oxycarbonyl]-5-azaspiro[2.4]heptane-6-carboxylic acid
- Molecular Formula:C16H30N2O5
- Molecular Weight:330.42
- CAS Registry Number:1499193-54-2
- EINECS:807-594-8
- Melting Point:
- Water Solubility:
CAS No.1499193-54-2 5-Azaspiro[2.4]heptane-5,6-dicarboxylic acid, 5-(1,1-dimethylethyl) ester, (6S)-, compd. with (2R)-2-amino-1-butanol (1:1)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.1499193-54-2 Factory Supply 5-Azaspiro[2.4]heptane-5,6-dicarboxylic acid, 5-(1,1-dimethylethyl) ester, (6S)-,compd. with (2R)-2-amino-1-butanol (1:1)
Assay:99.9% Appearance:Refer to COA Package:drum Storage:keep in cool and dry place Transportation:by sea or by air Application:Intermediates and materials
Min. Order:1
Supplier:Ality Chemical Corporation [
China (Mainland)]

Other Product
- 2006277-00-3/Methyl 4-[4-(Trifluoromethoxy)phenyl]pyrimidine-2-carboxylate
- 1382847-91-7/Methyl 5-bromo-4-methylpyridine-3-carboxylate
- 1040690-10-5/4-(Heptyloxy)-N-[2-(phenethyloxy)benzyl]aniline
- 1491917-83-9/Sacituzumab govitecan
- 1638768-01-0/Methyl 3-(((tert-butoxycarbonyl)amino)methyl)bicyclo[1.1.1]pentane-1-carboxylate
- 1185298-56-9/4-(tert-Butyl)phenyl 3-pyrrolidinylmethyl ether hydrochloride
- 13292-48-3/[(9E,19E)-26-[(E)-[2-(dimethylamino)ethyl-methylhydrazinylidene]methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
- 749269-77-0/Cyclopropanecarboxylic acid, 1-(2-fluoro-4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)-
- 944730-39-6/Cuprate(4-), [[3,3',3'',3'''-[(29H,31H-phthalocyanine-1,8,15,22-tetrayl-kappaN29,kappaN30,kappaN31,kappaN32)tetrakis(sulfonyl)]tetrakis[1-propanesulfonato]](6-)]-, sodium (1:4), (SP-4-1)-
- 356539-51-0/3-Chloro-N-(cyclopropylmethyl)-2-methylaniline
- 1289388-16-4/tert-Butyl 3-(((1-(pyrazin-2-yl)ethyl)amino)methyl)piperidine-1-carboxylate
- 5411-21-2/2-(7,8-Dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2h)-yl)ethyl propanoate
- 159002-28-5/2-Ethoxy-9-(5-O-phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine
- 29197-43-1/2-(2-Methylpropyl)-4-quinolinecarboxamide
- 1334714-66-7/Eravacycline dihydrochloride
- 152718-74-6/Trimethylsilyl 2,3,3,3-tetrafluoro-2-(1,1,2,2,3,3,3-heptafluoropropoxy)propanoate
- 1019111-23-9/[2-(3,5-Dimethyl-[1,2,4]triazol-4-yl)-phenoxy]-acetic acid
- 1132746-04-3/4-(2-{Propyl[(~2~H_7_)propyl]amino}ethyl)-1,3-dihydro-2H-indol-2-one
- 931107-55-0/2,2-Dimethyl-N~1~,N~3~-bis[(1R)-1-phenylethyl]propane-1,3-diamine
- 1499193-54-2/CID 156594291
- 1255502-07-8/Lithium (R)-3,5-dihydroxy-3-methylpentanoate
- 1286274-16-5/tert-Butyl (1R*,4R*)-4-(pentan-3-ylamino)cyclohexylcarbamate
- 1407997-83-4/(2R)-1-Boc-2-methyl-2-(methylaminomethyl)-pyrrolidine
- 946699-16-7/3-Fluoro-4-(2-isopropyl-5-methylphenoxy)aniline
- 80481-08-9/CID 11967908
- 121246-56-8/2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dicyclohexyl-5-((4-(dimethylamino)phenyl)methyl)-
- 66774-07-0/11-(4-chlorophenyl)-6H-benzo[c][1]benzoxepin-11-ol
- 161282-02-6/1-(4-Amino-3-methylphenyl)piperidin-4-ol
- 2304634-91-9/tert-butyl 3-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)azetidine-1-carboxylate
- 1021022-66-1/2-(2-Amino-5-fluorophenoxy)ethan-1-ol